Clinical Trial Update: A Six Month, Safety Follow-up Study in Eosinophilic Esophagitis Subjects Who Completed Study PR-021

View source ↗

Summary

This document reports the completion of a six-month safety follow-up study in eosinophilic esophagitis patients who completed Study PR-021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Snippet

Sponsor: Forest Laboratories | Conditions: Eosinophilic Esophagitis | Status: COMPLETED